Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Missense mutations in the triple helical region of the COL2A1 protein have been associated with lethal spondyloepiphyseal dysplasia (SED).
|
30932712 |
2019 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Similar skeletal disorders, such as spondyloepiphyseal dysplasias, are linked to mutations in type II collagen (COL2A1), but the causative gene in SEMD is not known.
|
28263186 |
2017 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
c.2224G>A (p.Gly687Ser) is a novel mutation of COL2A1 associated with spondyloepiphyseal dysplasia congenital.
|
25967556 |
2015 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Our study extends the mutation spectrum of SED and confirms a relationship between mutations in the COL2A1 gene and clinical findings of SED.
|
23079993 |
2012 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Most COL2A1 mutations occur in the triple helical region of alpha 1(II) chains: the SED spectrum is mostly attributed to missense mutations that substitute bulky amino acids for glycine residues, STD-I to haploinsufficiency of truncation mutations, and KND to exon skipping due to splice-site mutations.
|
15895462 |
2005 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Two human patients with spondyloepiphyseal dysplasia (SED) congenita have been reported with the same amino acid substitution at position 789 in the human COL2A1 gene.
|
12968670 |
2003 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutation in the COL2A1 gene has been identified in one family with spondyloepiphyseal dysplasia and calcium pyrophosphate and apatite crystalline deposits.
|
11333354 |
2001 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Having explained the digital findings and macrocephaly, the skeletal changes were thought to fit best congenital spondyloepiphyseal dysplasia (SEDC MIM #183900), a type II collagen disorder.
|
10678662 |
2000 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the COL2A1 gene have been identified in one family with spondyloepiphyseal dysplasia and secondary deposits of pyrophosphate and apatite crystalline deposits.
|
11123024 |
1999 |
Spondyloepiphyseal Dysplasia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hereditary osteoarthritis with mild spondyloepiphyseal dysplasia--are there "hot spots" on COL2A1?
|
8877930 |
1996 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Alternative splicing of exon 12 of the COL2A1 gene interrupts the triple helix of type-II collagen in the Kniest form of spondyloepiphyseal dysplasia.
|
8893763 |
1996 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Type II procollagen gene (COL2A1) mutation in exon 11 associated with spondyloepiphyseal dysplasia, tall stature and precocious osteoarthritis.
|
7738948 |
1995 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We analyzed the COL2A1 gene in a 27-year-old woman and her 47-year-old mother presenting with severe premature osteoarthrosis and X-ray signs compatible with mild spondyloepiphyseal dysplasia.
|
7866404 |
1994 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Kniest dysplasia is caused by dominant collagen II (COL2A1) mutations: parental somatic mosaicism manifesting as Stickler phenotype and mild spondyloepiphyseal dysplasia.
|
7700721 |
1994 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Spondyloepiphyseal dysplasia and precocious osteoarthritis in a family with an Arg75-->Cys mutation in the procollagen type II gene (COL2A1).
|
8244341 |
1993 |
Spondyloepiphyseal Dysplasia
|
0.500 |
Biomarker
|
disease |
CTD_human |
A mutation in the amino-terminal end of the triple helix of type II collagen causing severe osteochondrodysplasia.
|
8486375 |
1993 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Spondyloepiphyseal dysplasia in a Cape Town family: linkage with the gene for type II collagen (COL2A1).
|
1353665 |
1992 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
This case further documents the molecular basis of the spondyloepiphyseal dysplasia spectrum of chondrodysplasias as mutations in COL2A1.
|
1429602 |
1992 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
This mutation emphasizes the importance of COL2A1 mutations in producing the spondyloepiphyseal dysplasia phenotype.
|
1905723 |
1991 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mild spondyloepiphyseal dysplasia (Namaqualand type): genetic linkage to the type II collagen gene COL2A1.
|
1671807 |
1991 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Tandem duplication within a type II collagen gene (COL2A1) exon in an individual with spondyloepiphyseal dysplasia.
|
2339128 |
1990 |
Spondyloepiphyseal Dysplasia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
To confirm the validity of this hypothesis, the structure of the "candidate" type II collagen gene (COL2A1) has been directly examined in a relatively large SED family.
|
2543071 |
1989 |
Spondyloepiphyseal Dysplasia
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|